Delivery Order SPE2DR25D1106-SPE2DR26FHZ8A
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $2,564.77 delivery order by the Defense Logistics Agency on September 8, 2025, for the supply of Ambien CR 6.25 mg tablets (100 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) on September 23, 2025, valued at $4,288.38 with an ultimate completion date of September 24, 2025. The contract is for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This award represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,360.04 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a major distribution hub for...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, valued at $1,804.72. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for 100 tablets of Ambien CR 6.25 mg with a contract value of $6,267.76. The order was competitively awarded on September 24, 2025, with a firm fixed price structure and an ultimate completion date of September 25, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,076.82 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units). The contract was awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a competitively awarded, non-set-aside transaction with firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) under a firm fixed-price contract. The order, valued at $1,771.82, was competitively awarded without set-aside designation and is scheduled for completion by November 3, 2025. This delivery order is executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,116.22 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100 count) on October 24, 2025, with an ultimate completion date of October 27, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is classified as a child contract under the company's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The place of performance is...
- AmerisourceBergen Drug Corp was awarded a delivery order contract on August 7, 2025, by the Defense Logistics Agency's Medical Supply Chain to deliver 100 tablets of Ambien CR 6.25 mg for a ceiling value of $2,469.39. This is a firm fixed price, non-set-aside competitively awarded delivery order with an ultimate completion date of August 8, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $1,052.07. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FHZ8ADelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $5.74K firm fixed-price delivery order from the Defense Logistics Agency (DLA) on November 17, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count bottles). The contract, which carries no set-aside designation, represents a competitively awarded transaction with an ultimate completion date of November 18, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999.999 billion through December 2026 that enables the company to provide pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical vendor within the DLA's medical supply chain, fulfilling pharmaceutical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This particular delivery order for Ambien CR contributes to the broader pharmaceutical support mission that the DLA maintains to ensure consistent medication availability for military personnel and veterans throughout the service medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 11/17/25 |